NCT00860951

Brief Summary

The purpose of this research is to develop tools enable people who are paralyzed to operate technology and access computers. These tools are called brain computer interfaces (BCIs). BCIs would let a person use brain signals to operate technology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at P25-P50 for phase_1 healthy

Timeline
Completed

Started Sep 2008

Longer than P75 for phase_1 healthy

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 13, 2009

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

June 11, 2015

Completed
Last Updated

July 9, 2015

Status Verified

May 1, 2015

Enrollment Period

3.7 years

First QC Date

March 11, 2009

Results QC Date

May 27, 2015

Last Update Submit

June 10, 2015

Conditions

Keywords

Normal

Outcome Measures

Primary Outcomes (1)

  • Accuracy of Typing With BCI Keyboard.

    Accuracy for the sentence typed in each environment was calculated as the percentage of characters for which the result character matched the target character. The target characters were determined based on the next character needed to complete the sentence to be copied. In the case of errors, the next character was therefore a backspace to correct the error. The target characters were modified by subject comments to account for errors in selecting the next character. Once sentence was typed in each environment in each session on a separate day. From the three repeated sessions, there were therefore 9 total sentences per subject with 3 measures for each environment. These were treated as repeated measures for the analysis.

    mean score from 3 sessions over 29 days

Study Arms (1)

Brain Computer Interface Keyboard

OTHER

What effect does the environment (BCI, AT device, Computer) have on the accuracy of typing using a BCI keyboard?

Device: Brain Computer Interface Keyboard

Interventions

Subjects will wear an EEG cap for 1-4 hours (1-2 hours typical) per session and use the brain-computer interface to operate assistive technology. Subjects will be asked to participate in 3 sessions.

Brain Computer Interface Keyboard

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older.
  • Able to read text on a computer screen
  • Able to understand and remember instructions concerning participation

You may not qualify if:

  • Unable give informed consent.
  • Unable to understand and follow instructions.
  • Have abnormal tone or uncontrolled movements in the head-and-neck that would interfere with EEG recordings.
  • Known to have photosensitive epilepsy.
  • Open head lesions or sores

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Michigan Direct Brain Interface Project

Ann Arbor, Michigan, 48109, United States

Location

Wadsworth Center

Albany, New York, 12201, United States

Location

MeSH Terms

Conditions

Amyotrophic Lateral SclerosisNeuromuscular DiseasesSpinal Cord InjuriesCerebral Palsy

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesTrauma, Nervous SystemWounds and InjuriesBrain Damage, ChronicBrain Diseases

Results Point of Contact

Title
Jane Huggins
Organization
University of Michigan

Study Officials

  • Jane Huggins, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

March 11, 2009

First Posted

March 13, 2009

Study Start

September 1, 2008

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

July 9, 2015

Results First Posted

June 11, 2015

Record last verified: 2015-05

Locations